- Previous Close
76.34 - Open
76.13 - Bid 75.16 x 800
- Ask 76.50 x 900
- Day's Range
75.85 - 77.75 - 52 Week Range
47.16 - 85.92 - Volume
1,367,019 - Avg. Volume
1,122,043 - Market Cap (intraday)
13.255B - Beta (5Y Monthly) --
- PE Ratio (TTM)
27.76 - EPS (TTM)
2.76 - Earnings Date May 5, 2025 - May 20, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
80.89
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. Its Purification and Filtration segment provides purification and filtration technologies comprising filters, purifiers, cartridges, and membranes. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.
www.solventum.com22,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: SOLV
View MorePerformance Overview: SOLV
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SOLV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SOLV
View MoreValuation Measures
Market Cap
13.21B
Enterprise Value
20.46B
Trailing P/E
27.66
Forward P/E
13.39
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.61
Price/Book (mrq)
4.46
Enterprise Value/Revenue
2.48
Enterprise Value/EBITDA
13.40
Financial Highlights
Profitability and Income Statement
Profit Margin
5.80%
Return on Assets (ttm)
4.81%
Return on Equity (ttm)
6.55%
Revenue (ttm)
8.25B
Net Income Avi to Common (ttm)
479M
Diluted EPS (ttm)
2.76
Balance Sheet and Cash Flow
Total Cash (mrq)
762M
Total Debt/Equity (mrq)
276.55%
Levered Free Cash Flow (ttm)
1.3B